tiprankstipranks
Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market

Xilio Therapeutics (XLO) Balance Sheet

95 Followers

Xilio Therapeutics Balance Sheet

Xilio Therapeutics's total assets for Q3 2023 were $77.84M, a decrease of -15.73% from the previous quarter. XLO total liabilities were $25.34M for the fiscal quarter, a 1.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 139.16M$ 218.06M$ 36.32M$ 62.72M
Total Liabilities
$ 33.52M$ 32.63M$ 119.60M$ 92.25M
Total Equity Gross Minority
$ 105.65M$ 185.43M$ -83.29M$ -29.52M
Total Capitalization
$ 121.17M$ 195.06M$ -75.88M$ -19.91M
Preferred Stock Equity
----
Capital Lease Obligations
--$ 11.47M$ 9.02M
Currency in USD

Xilio Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis